Therapeutics for rheumatic fever and rheumatic heart disease.
Anna P RalphBart J CurriePublished in: Australian prescriber (2022)
The goals of acute rheumatic fever therapy are to relieve symptoms, mitigate cardiac valve damage and eradicate streptococcal infection. Preventing future recurrences requires long-term secondary antibiotic prophylaxis and ongoing prevention of Streptococcus pyogenes (group A streptococcus) infections The recommended regimen for secondary prophylaxis comprises benzathine benzylpenicillin G intramuscular injections every four weeks. For patients with non-severe or immediate penicillin hypersensitivity, use erythromycin orally twice daily The goals of therapy for rheumatic heart disease are to prevent progression and optimise cardiac function. Secondary antibiotic prophylaxis can reduce the long-term severity of rheumatic heart disease Patients with rheumatic heart disease, including those receiving benzathine benzylpenicillin G prophylaxis, should receive amoxicillin prophylaxis before undergoing high-risk dental or surgical procedures. If they have recently been treated with a course of penicillin or amoxicillin, or have immediate penicillin hypersensitivity, clindamycin is recommended.
Keyphrases
- rheumatoid arthritis
- pulmonary hypertension
- drug induced
- stem cells
- physical activity
- biofilm formation
- oxidative stress
- small molecule
- mitral valve
- pseudomonas aeruginosa
- staphylococcus aureus
- public health
- intensive care unit
- early onset
- mesenchymal stem cells
- cystic fibrosis
- cell therapy
- sleep quality
- acute respiratory distress syndrome
- preterm birth
- extracorporeal membrane oxygenation